These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 12481767)
1. Are new laws needed to protect human subjects? Zucker C Account Res; 2001; 8(3):235-44. PubMed ID: 12481767 [No Abstract] [Full Text] [Related]
2. Institutional review boards (IRBs) failed to use steps to protect vulnerable research subjects. Maloney DM Hum Res Rep; 2003 Jun; 18(6):6-7. PubMed ID: 15119342 [No Abstract] [Full Text] [Related]
3. Bioethical malpractice: risk and responsibilities in human research. Noah BA J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441 [No Abstract] [Full Text] [Related]
4. New requirements for vulnerable subjects and IRB membership. Maloney DM Hum Res Rep; 2000 Oct; 15(10):9. PubMed ID: 11917935 [No Abstract] [Full Text] [Related]
5. Recurrent issues in the review of medical research on human subjects. Moore DL Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123 [No Abstract] [Full Text] [Related]
6. Model federal policy on protection of human subjects is now final. Maloney DM Hum Res Rep; 1991 Aug; 6(8):1-3. PubMed ID: 16145785 [No Abstract] [Full Text] [Related]
7. Research administrator should not serve on institutional review board. Maloney DM Hum Res Rep; 2002 Apr; 17(4):6-7. PubMed ID: 12374181 [No Abstract] [Full Text] [Related]
8. Financial conflicts of interest and protection of human research subjects. Maloney DM Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034 [No Abstract] [Full Text] [Related]
9. An introduction to NBAC's report on research involving persons with mental disorders that may affect decisionmaking capacity. Childress JF Account Res; 1999; 7(2-4):101-15. PubMed ID: 11658169 [No Abstract] [Full Text] [Related]
10. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards. Saver RS William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924 [No Abstract] [Full Text] [Related]
11. Regulating research on the terminally ill: a proposal for heightened safeguards. Addicott DC J Contemp Health Law Policy; 1999; 15(2):479-524. PubMed ID: 10394764 [No Abstract] [Full Text] [Related]
12. University's Multiple Project Assurance (MPA) could be renewed for only short periods of time. Maloney DM Hum Res Rep; 2000 Jul; 15(7):5-6. PubMed ID: 12199226 [No Abstract] [Full Text] [Related]
13. Are research ethics bad for our mental health? Michels R N Engl J Med; 1999 May; 340(18):1427-30. PubMed ID: 10228197 [No Abstract] [Full Text] [Related]
14. Institutional review boards not sufficiently monitoring recruitment of human subjects. Maloney DM Hum Res Rep; 2000 Aug; 15(8):1-3. PubMed ID: 12199290 [No Abstract] [Full Text] [Related]
15. Improving protection for research subjects. Steinbrook R N Engl J Med; 2002 May; 346(18):1425-30. PubMed ID: 11986426 [No Abstract] [Full Text] [Related]
16. Research involving children: regulations, review boards and reform. Gandhi R J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026 [No Abstract] [Full Text] [Related]
17. Institutional review boards and financial conflicts of interest. Maloney DM Hum Res Rep; 2002 Feb; 17(2):1-2. PubMed ID: 12374174 [No Abstract] [Full Text] [Related]
18. Widespread IRB-related compliance problems at research institution. Maloney DM Hum Res Rep; 2001 Jan; 16(1):6-7. PubMed ID: 11855427 [No Abstract] [Full Text] [Related]
19. New federalwide assurance for protection of human subjects. Maloney DM Hum Res Rep; 2001 Jan; 16(1):1-2. PubMed ID: 11855423 [No Abstract] [Full Text] [Related]
20. Protecting research subjects--what must be done. Shalala D N Engl J Med; 2000 Sep; 343(11):808-10. PubMed ID: 10984573 [No Abstract] [Full Text] [Related] [Next] [New Search]